International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1353-1360 , 1 August 2006

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival

  • Dawn L. Hershman, M.D., M.S.

      Affiliations

    • Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons
    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • New York Presbyterian Hospital, New York, NY
    • Corresponding Author InformationReprint requests to: Dawn Hershman, M.D., M.S., Herbert Irving Comprehensive Cancer Center, 161 Ft. Washington, Room 1068, New York, NY 10032. Tel: (212) 305-1945; Fax: (212) 305-0178
    • ,
  • Xiaoyan Wang, M.S.

      Affiliations

    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • ,
  • Russell McBride, M.P.H.

      Affiliations

    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • ,
  • Judith S. Jacobson, Dr.P.H.

      Affiliations

    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • ,
  • Victor R. Grann, M.D., M.P.H.

      Affiliations

    • Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons
    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • New York Presbyterian Hospital, New York, NY
    • ,
  • Alfred I. Neugut, M.D., Ph.D.

      Affiliations

    • Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons
    • Department of Epidemiology, Mailman School of Public Health, Columbia University
    • New York Presbyterian Hospital, New York, NY

Received 16 January 2006 ,Revised 12 March 2006 ,Accepted 14 March 2006.

References 

  1. Early Breast Cancer Trialists’ Collaborative Group . Polychemotherapy for early breast cancer (An overview of the randomised trials) . Lancet . 1998;352(9132):930–942
  2. Early Breast Cancer Trialists’ Collaborative Group . Tamoxifen for early breast cancer (An overview of the randomised trials) . Lancet . 1998;351:1451–1467
  3. Whelan TJ , Julian J , Wright J , Jadad AR , Levine ML . Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis . J Clin Oncol . 2000;18:1220–1229
  4. Early Breast Cancer Trialists’ Collaborative Group . Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer (An overview of the randomised trials) . Lancet . 2000;355:1757–1770
  5. Recht A , Edge SB , Solin LJ , et al.   Postmastectomy radiotherapy (Clinical practice guidelines of the American Society of Clinical Oncology) . J Clin Oncol . 2001;19:1539–1569
  6. Coburn NG , Chung MA , Fulton J , Cady B . Decreased breast cancer tumor size, stage, and mortality in Rhode Island (An example of a well-screened population) . Cancer Control . 2004;11:222–230
  7. Caplan LS , Helzlsouer KJ , Shapiro S , Freedman LS , Coates RJ , Edwards BK . System delay in breast cancer in whites and blacks . Am J Epidemiol . 1995;142:804–812
  8. Caplan LS , Wells BL , Haynes S . Breast cancer screening among older racial/ethnic minorities and whites (Barriers to early detection) . J Gerontol . 1992;47(Spec. No.):101–110
  9. Bickell NA , Young GJ . Coordination of care for early-stage breast cancer patients . J Gen Intern Med . 2001;16:737–742
  10. Freeman HP , Muth BJ , Kerner JF . Expanding access to cancer screening and clinical follow-up among the medically underserved . Cancer Pract . 1995;3:19–30
  11. Richards MA , Westcombe AM , Love SB , Littlejohns P , Ramirez AJ . Influence of delay on survival in patients with breast cancer (A systematic review) . Lancet . 1999;353:1119–1126
  12. Huang J , Barbera L , Brouwers M , Browman G , Mackillop WJ . Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review . J Clin Oncol . 2003;21:555–563
  13. Hebert-Croteau N , Freeman CR , Latreille J , Brisson J . Delay in adjuvant radiation treatment and outcomes of breast cancer—a review . Breast Cancer Res Treat . 2002;74:77–94
  14. Hebert-Croteau N , Freeman CR , Latreille J , Rivard M , Brisson J . A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer . Breast Cancer Res Treat . 2004;88:187–196
  15. Vujovic O , Perera F , Dar AR , et al.   Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? . Int J Radiat Oncol Biol Phys . 1998;40:869–874
  16. Warren JL , Harlan LC , Fahey A , et al.   Utility of the SEER-Medicare data to identify chemotherapy use . Med Care . 2002;40(8 Suppl): IV-55–61
  17. Warren JL , Klabunde CN , Schrag D , Bach PB , Riley GF . Overview of the SEER-Medicare data (Content, research applications, and generalizability to the United States elderly population) . Med Care . 2002;40(8 Suppl): IV-3–18
  18. Du XL , Osborne C , Goodwin JS . Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer . J Clin Oncol . 2002;20:4636–4642
  19. Du X , Freeman JL , Goodwin JS . Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results . J Clin Epidemiol . 1999;52:463–470
  20. Charlson ME , Sax FL , MacKenzie CR , Fields SD , Braham RL , Douglas RG . Assessing illness severity (Does clinical judgment work?) . J Chronic Dis . 1986;39:439–452
  21. Deyo RA , Cherkin DC , Ciol MA . Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases . J Clin Epidemiol . 1992;45:613–619
  22. Klabunde CN , Potosky AL , Legler JM , Warren JL . Development of a comorbidity index using physician claims data . J Clin Epidemiol . 2000;53:1258–1267
  23. NIH consensus conference . Treatment of early-stage breast cancer . JAMA . 1991;265:391–395
  24. Buzdar AU , Kau SW , Smith TL , et al.   The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer . Cancer . 1993;71:3680–3684
  25. Recht A , Come SE , Gelman RS , et al.   Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer (Sequencing, timing, and outcome) . J Clin Oncol . 1991;9:1662–1667
  26. Clarke DH , Le MG , Sarrazin D , et al.   Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy (Experience of the Institut Gustave-Roussy) . Int J Radiat Oncol Biol Phys . 1985;11:137–145
  27. Nixon AJ , Recht A , Neuberg D , et al.   The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy . Int J Radiat Oncol Biol Phys . 1994;30:17–21
  28. Froud PJ , Mates D , Jackson JS , et al.   Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence . Int J Radiat Oncol Biol Phys . 2000;46:363–372
  29. Caplan LS , Helzlsouer KJ , Shapiro S , Wesley MN , Edwards BK . Reasons for delay in breast cancer diagnosis . Prev Med . 1996;25:218–224
  30. Gwyn K , Bondy ML , Cohen DS , et al.   Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma . Cancer . 2004;100:1595–1604
  31. Shavers VL , Harlan LC , Stevens JL . Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 . Cancer . 2003;97:134–147
  32. Ghafoor A , Jemal A , Ward E , Cokkinides V , Smith R , Thun M . Trends in breast cancer by race and ethnicity . CA Cancer J Clin . 2003;53:342–355
  33. Albain U, Green , Hutchins , Rivkin , Martino , Livingston , et al. Outcome of African Americans on the Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials [Abstract] . Breast Cancer Res Treat . 2003;82(Suppl): 21
  34. Schroen AT , Brenin DR , Kelly MD , Knaus WA , Slingluff CL . Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients . J Clin Oncol . 2005;23:7074–7080
  35. Haggstrom DA , Quale C , Smith-Bindman R . Differences in the quality of breast cancer care among vulnerable populations . Cancer . 2005;104:2347–2358
  36. Hatzell TA , Ricketts TC , Tropman SE , Paskett ED , Cooper MR . Rural physicians’ understanding of the state-of-the-art in breast, colon and rectum cancer treatment . Cancer Causes Control . 1999;10:261–267
  37. Tropman SE , Ricketts TC , Paskett E , Hatzell TA , Cooper MR , Aldrich T . Rural breast cancer treatment (Evidence from the Reaching Communities for Cancer Care (REACH) project) . Breast Cancer Res Treat . 1999;56:59–66
  38. Murri R , Ammassari A , Trotta MP , et al.   Patient-reported and physician-estimated adherence to HAART (Social and clinic center-related factors are associated with discordance) . J Gen Intern Med . 2004;19:1104–1110
  39. Jackevicius CA , Mamdani M , Tu JV . Adherence with statin therapy in elderly patients with and without acute coronary syndromes . JAMA . 2002;288:462–467
  40. Waeber B , Leonetti G , Kolloch R , McInnes GT . Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study . J Hypertens . 1999;17:1041–1045
  41. Misdrahi D , Llorca PM , Lancon C , Bayle FJ . [Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications] . Encephale . 2002;28(3 Pt 1):266–272
  42. McDonnell PJ , Jacobs MR . Hospital admissions resulting from preventable adverse drug reactions . Ann Pharmacother . 2002;36:1331–1336
  43. Horwitz RI , Horwitz SM . Adherence to treatment and health outcomes . Arch Intern Med . 1993;153:1863–1868
  44. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project . N Engl J Med . 1980;303:1038–1041
  45. Wood WC , Budman DR , Korzun AH , et al.   Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma . N Engl J Med . 1994;330:1253–1259
  46. Hryniuk W . Re (Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer) . J Natl Cancer Inst . 1999;91:1425
  47. Budman DR , Berry DA , Cirrincione CT , et al.  The Cancer and Leukemia Group B   Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer . J Natl Cancer Inst . 1998;90:1205–1211

 Dr. Hershman is the recipient of an American Society of Clinical Oncology Career Development Award and a K07 Award from the National Cancer Institute (NCI) (CA95597). Dr. Neugut is the recipient of a K05 Award from the NCI (CA89155) and a grant from the American Cancer Society (RSGT-01-024-04-CPHPS). Mr. McBride is the recipient of a T32 fellowship from NCI (CA09529).This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Branch, Division of Cancer Prevention and Population Science, NCI; the Office of Information Services, and the Office of Strategic Planning, Health Care Financing Administration; Information Management Services, Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database.

PII: S0360-3016(06)00583-9

doi: 10.1016/j.ijrobp.2006.03.048

International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1353-1360 , 1 August 2006

Article Tools

* Image Usage & Resolution